Equities
Health CareHealth Care Providers
  • Price (USD)600.50
  • Today's Change23.50 / 4.07%
  • Shares traded779.00
  • 1 Year change+12.22%
  • Beta0.5857
Data delayed at least 15 minutes, as of Nov 21 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Dec-23
  • 19-Sep-24
  • 17-Oct-24
  • 14-Nov-24
Select bar for recommendation details.
Recommendations14-Nov-24
Buy11
Outperform15
Hold4
Sell0
Strong Sell0

Share price forecast in USD

The 26 analysts offering 12 month price targets for UnitedHealth Group Inc have a median target of 623.50, with a high estimate of 715.00 and a low estimate of 551.12. The median estimate represents a 3.83% increase from the last price of 600.50.
High19.1%715.00
Med3.8%623.50
Low-8.2%551.12

Dividends in USD

In 2023, Unitedhealth Group Inc reported a dividend of 7.29 USD, which represents a 13.91% increase over last year. The 9 analysts covering the company expect dividends of 8.02 USD for the upcoming fiscal year, an increase of 10.07%.
Div growth (TTM)13.91%
More ▼

Earnings history & estimates in USD

On Oct 15, 2024, UnitedHealth Group Inc reported 3rd quarter 2024 earnings of 7.15 per share. This result was in line with the consensus of the 23 analysts following the company and exceeded last year's 3rd quarter results by 8.99%.
The next earnings announcement is expected on Jan 10, 2025.
Average growth rate+2.41%
UnitedHealth Group Inc reported annual 2023 earnings of 25.12 per share on Jan 12, 2024.
Average growth rate+13.57%
More ▼

Revenue history & estimates in USD

UnitedHealth Group Incorporated had 3rd quarter 2024 revenues of 100.82bn. This bettered the 99.28bn consensus of the 17 analysts covering the company. This was 9.67% above the prior year's 3rd quarter results.
Average growth rate+2.24%
UnitedHealth Group Incorporated had revenues for the full year 2023 of 371.62bn. This was 14.64% above the prior year's results.
Average growth rate+11.35%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.